Telix upgraded on FY outlook as analysts publish bullish notes
MELBOURNE: Investors swarmed to ASX-listed Telix Pharmaceuticals after its first-quarter revenue jumped 62 per ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
